Mechanical assist devices in advanced heart failure. Indications and perspectives;Assistenza ventricolare meccanica nell'insufficienza cardiaca avanzata. Indicazioni e prospettive

Giornale Italiano di Cardiologia

Volumn 7, Issue 2, 2006, Pages 91-108

  Colombo, Tiziano ^a   Russo, Claudio ^a   Lanfranconi, Marco ^a   Bruschi, Giuseppe ^a   Garatti, Andrea ^a   Milazzo, Filippo ^a   Catena, Emanuele ^a   Oliva, Fabrizio ^a   Turazza, Fabio ^a   Frigerio, Maria ^a   Vitali, Ettore ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Heart failure; Heart transplantation

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; ASSISTED CIRCULATION; BIOCOMPATIBILITY; BLOOD PUMP; CAUSE OF DEATH; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DONOR; EXERCISE; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HUMAN; POSTOPERATIVE COMPLICATION; PUBLIC HEALTH; RELIABILITY; TERMINALLY ILL PATIENT; THROMBOEMBOLISM; TREATMENT INDICATION; PATIENT SELECTION; REVIEW; STANDARD;

HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION;

EID: 33645645066     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Morgan S, Smith H, Simpson J, et al. Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in a general practice setting: cross-sectional survey. BMJ 1999; 318: 368-72.
2. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 guidelines for the evaluation and management of heart failure). Developed in collaboration with the International Society for Heart and Lung Transplantation; endorsed by the Heart Failure Society of America. Circulation 2001; 104: 2996-3007.
3. Eriksson H. Heart failure. A growing public health problem. J Intern Med 1995; 237: 135-41.
4. Schocken DD, Arietta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301-6.
5. Robbins RC, Barlow CW, Oyer PE, et al. Thirty years of cardiac transplantation at Stanford University. J Thorac Cardiovasc Surg 1999; 117: 939-51.
6. Tavazzi L. Epidemiology of dilated heart failure: a still undetermined entity. Eur Heart J 1997; 18: 4-6.
7. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report - 2004. J Heart Lung Transplant 2004; 23: 796-803.
8. Hunt SA, Frazier OH. Mechanical circulatory support and cardiac transplantation. Circulation 1998; 97: 2079-90.
9. Spencer FC, Eiseman B, Trinkle JK, Rossi NP. Assisted circulation for cardiac failure following intracardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1965; 49: 56-73.
10. DeBakey ME. Left ventricular bypass pump for cardiac assistance: clinical experience. Am J Cardiol 1971; 27: 3-11.
11. Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol 1969; 24: 723-30.
12. Norman JC, Cooley DA, Kahan BD, et al. Total support of the circulation of a patient with postcardiotomy stone-heart syndrome by a partial artificial heart (ALVAD) for 5 days followed by heart and kidney transplantation. Lancet 1978; 1: 1125-7.
13. Portner PM, Oyer PE, McGregor CG, et al. First human use of an electrically powered implantable ventricular assist system. (abstr) Artif Organs 1985; 9: 36.
14. Levinson MM, Smith RG, Cork R, et al. Three recent cases of the total artificial heart before transplantation. J Heart Transplant 1986; 5: 215-28.
15. Hill JC, Farrar DJ, Hershon JJ, et al. Use of a prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N Engl J Med 1986; 314: 626-8.
16. Rose EA, Gelijns AC, Moskowitz AJ, et al, for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345: 1435-43.
17. Weitkemper HH, El-Banayosy A, Arusoglu L, et al. Mechanical circulatory support: reality and dreams. Experience of a single center. J Extra Corpor Technol 2004; 36: 169-73.
18. Lanfranconi M, Russo C, Garatti A, et al. LVAD outpatien therapy. Insuffisance cardiaque et transplantation. Journées de La Pitié 2000: 215-7.
19. Novacor© LVAS. Available at: http://www.worldheart.com/section5/ novacor.html. Accessed January 2004.
20. Casimir-Ahn H, Lonn U, Peterzen B. Clinical use of the Hemopump cardiac assist system for circulatory support. Ann Thorac Surg 1995; 59 (Suppl): S39-S45.
21. Nose Y, Yoshikawa M, Murabayashi S, Takano T. Development of rotary blood pump technology: past, present and future. Artif Organs 2000; 24: 412-20.
22. Garatti A, Colombo T, Russo C, et al. Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump. J Heart Lung Transplant 2005; 24: 481-5.
23. Colombo T, Garatti A, Bruschi G, et al. First successful bridge to recovery with the Impella Recover 100 left ventricular assist device for fulminant acute myocarditis. Ital Heart J 2003; 4: 642-5.
24. Meyns B, Dens J, Sergeant P, et al. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock. Thorac Cardiovasc Surg 2003; 51: 312-7.
25. Kiyotaka F, McCarthy PM, Smedira NG, et al. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg 1999; 68: 2181-4.
26. Chen JM, Rose EA. Management of perioperative right-sided circulatory failure. In: Goldstein DJ, Oz MC, eds. Cardiac assist devices. Armonk, NY: Futura Publishing Company, 2000: 83-101.
27. Deng MC, Loebe M, El-Banayosy A, et al. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation 2001; 103: 231-7.
28. Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001; 122: 1186-95.
29. El-Banayosy A, Arusoglu L, Kizner L, et al. Predictors of survival in patients bridged to transplantation with the Thoratec VAD device: a single-center retrospective study on more than 100 patients. J Heart Lung Transplant 2000; 19: 964-8.
30. Reinhartz O, Farrar DJ, Hershon JH, et al. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist device as a bridge to transplantation. J Thorac Cardiovasc Surg 1998; 116: 633-40.
31. Oz MC, Goldstein DJ, Pepino P, et al. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation 1995; 92 (Suppl): II169-II173.
32. Gracin N, Johnson MR, Spokas D, et al. The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation. J Heart Lung Transplant 1998; 17: 1017-23.
33. Williams MR, Oz MC. Indications and patient selection for mechanical ventricular assistance. Ann Thorac Surg 2001; 71 (Suppl): S86-S91.
34. Friedel N, Viazis P, Schiessler A, et al. Recovery of end-organ failure during mechanical circulatory support. Eur J Cardiothorac Surg 1992; 6: 519-23.
35. Pagani FD, Aaronson KD, Swaniker F, Bartlett RH. The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device. Ann Thorac Surg 2001; 71 (Suppl): S77-S81.
36. Pavie A, Leger P, Regan M, et al. Clinical experience with a total artificial heart as a bridge for transplantation: the Pitie experience. J Card Surg 1995; 10: 552-8.
37. Kaplon RJ, Gillinov AM, Smedira NG, et al. Vitamin K reduces bleeding in left ventricular assist device recipients. J Heart Lung Transplant 1999; 18: 346-50.
38. Blee TH, Cogbill TH, Lambert PJ. Hemorrhage associated with vitamin C deficiency in surgical patients. Surgery 2002; 131: 408-12.
39. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998; 331: 1522-33.
40. Szefner J, Cabrol C. Control and treatment of hemostasis in patients with a total artificial heart: the experience of La Pitié. In: Pifarre R, ed. Anticoagulation, hemostasis, and blood preservation in cardiovascular surgery. Philadelphia, PA: Hanley & Belfus, 1993: 237-68.
41. Holman WL, Murrah CP, Ferguson ER, et al. Infections during extended circulatory support: University of Alabama at Birmingham experience 1989 to 1994. Ann Thorac Surg 1996; 61: 366-71.
42. Foray A, Williams D, Reemtsma K, Oz M, Mancini D. Assessment of submaximal exercise capacity in patients with left ventricular assist devices. Circulation 1996; 94 (Suppl): 11222-11226.
43. Nishimura S, Radovancevic B, Odegaard P, Myers T, Springer W, Frazier OH. Exercise capacity recovers slowly but fully in patients with a left ventricular assist device. ASAIO J 1996; 42: M568-M570.
44. Mussivand T, Kung RT, McCarthy PM, et al. Cost-effectiveness of artificial organ technologies versus conventional therapy. ASAIO J 1997; 43: 230-6.
45. Mussivand T, Paganini EP, Oz MC, Smedira NG. Cost-effectiveness of artificial organ therapies. ASAIO J 1998; 44: 253-8.
46. Moskowitz AJ, Weinberg AD, Oz MC, Williams DL. Quality of life with an implanted left ventricular assist device. Ann Thorac Surg 1997; 64: 1764-9.
47. Catanese KA, Goldstein DJ, Williams DL, et al. Outpatient left ventricular assist device support: a new destination rather than a bridge. Ann Thorac Surg 1996; 62: 646-52.
48. Digiorgi PL, Reel MS, Thornton B, Burton E, Naka Y, Oz MC. Heart transplant and left ventricular assist device costs. J Heart Lung Transplant 2005; 24: 200-4.
49. Hetzer R, Muller J, Weng Y, et al. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg 1999; 68: 742-9.
50. Muller J, Wallukat G, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997; 96: 542-9.
51. Rivello H, Meckert P, Vigliano C, Favaloro R, Loguens RP. Cardiac myocyte nuclear size and ploidy status decrease after mechanical support. Cardiovasc Pathol 2001; 10: 53-7.
52. Bruckner B, Stetson S, Perez-Verdia A, et al. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 2001; 20: 457-64.
53. Sodian R, Loebe M, Schmitt C, et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol 2001; 38: 1942-9.